26 results
8-K
EX-99.3
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
(“IRB”) or independent ethics committee approval at each clinical trial site;
delays in recruiting suitable subjects to participate in Tenet’s
8-K
EX-99.2
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
trials may begin and must be updated annually or when significant changes are made;
approval by an institutional review board (“IRB”) or ethics committee
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
or obtaining required institutional review board (“IRB”) or independent ethics committee approval at each clinical trial site;
delays in recruiting … be updated annually or when significant changes are made;
approval by an IRB or ethics committee for each clinical site before the trial may commence
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
”) and clinical trial sites;
delays in opening clinical trial sites or obtaining required institutional review board (“IRB”) or independent ethics committee … be updated annually or when significant changes are made;
approval by an IRB or ethics committee for each clinical site before the trial may commence
DEF 14A
h34aam52ntbx v7
8 Apr 22
Definitive proxy
4:20pm
10-K
pqtep89pz pxuxil
7 Mar 22
Annual report
4:03pm
10-Q
bb4o cnk0j0lj0
13 Sep 21
Quarterly report
4:01pm
424B4
h8awo
11 Aug 21
Prospectus supplement with pricing info
5:05pm